MetLife Investment Management, LLC - MYRIAD GENETICS INC ownership

MYRIAD GENETICS INC's ticker is MYGN and the CUSIP is 62855J104. A total of 260 filers reported holding MYRIAD GENETICS INC in Q2 2018. The put-call ratio across all filers is 0.72 and the average weighting 0.1%.

Quarter-by-quarter ownership
MetLife Investment Management, LLC ownership history of MYRIAD GENETICS INC
ValueSharesWeighting
Q3 2023$684,411
-30.8%
42,6690.0%0.01%
-28.6%
Q2 2023$989,067
-0.2%
42,6690.0%0.01%0.0%
Q1 2023$991,201
+60.1%
42,6690.0%0.01%
+40.0%
Q4 2022$619,127
-24.0%
42,6690.0%0.01%
-28.6%
Q3 2022$814,125
+5.0%
42,6690.0%0.01%
+16.7%
Q2 2022$775,296
-27.9%
42,6690.0%0.01%
-14.3%
Q1 2022$1,075,259
+42.1%
42,669
+55.6%
0.01%
+16.7%
Q4 2021$756,626
-14.5%
27,4140.0%0.01%
-25.0%
Q3 2021$885,198
+5.6%
27,4140.0%0.01%0.0%
Q2 2021$838,320
+0.4%
27,4140.0%0.01%0.0%
Q1 2021$834,756
+32.7%
27,414
-13.8%
0.01%
+33.3%
Q4 2020$629,122
+51.6%
31,8140.0%0.01%
+20.0%
Q3 2020$414,855
+15.0%
31,8140.0%0.01%
+25.0%
Q2 2020$360,771
-20.8%
31,8140.0%0.00%
-33.3%
Q1 2020$455,258
-47.4%
31,8140.0%0.01%
-33.3%
Q4 2019$866,295
-4.9%
31,8140.0%0.01%
-10.0%
Q3 2019$910,835
+3.1%
31,8140.0%0.01%0.0%
Q2 2019$883,792
-10.6%
31,814
+6.9%
0.01%
-9.1%
Q1 2019$988,132
+14.2%
29,7630.0%0.01%0.0%
Q4 2018$865,210
-36.8%
29,7630.0%0.01%
-21.4%
Q3 2018$1,369,098
+23.1%
29,7630.0%0.01%
+7.7%
Q2 2018$1,112,000
+26.5%
29,7630.0%0.01%
+30.0%
Q1 2018$879,000
-14.0%
29,7630.0%0.01%
-16.7%
Q4 2017$1,022,00029,7630.01%
Other shareholders
MYRIAD GENETICS INC shareholders Q2 2018
NameSharesValueWeighting ↓
Camber Capital Management LP 4,000,000$45,360,0002.60%
Tieton Capital Management, LLC 166,441$1,887,0002.36%
S&T BANK/PA 315,835$3,582,0000.82%
DISCIPLINED GROWTH INVESTORS INC /MN 2,194,204$24,882,0000.60%
XTX MARKETS LLC 14,807$168,0000.57%
Glenview Capital Management 1,810,727$20,534,0000.57%
EARNEST PARTNERS LLC 4,761,082$53,991,0000.51%
AIMZ Investment Advisors, LLC 42,685$484,0000.31%
DUALITY ADVISERS, LP 163,717$1,857,0000.17%
Engineers Gate Manager LP 219,922$2,494,0000.13%
View complete list of MYRIAD GENETICS INC shareholders